Drug Discovery World

MAY 1, 2024

This is reflected in collaboration and investment patterns; in 2023, Antiverse, a biotechnology company developing a computational antibody drug discovery platform, raised seed funding totalling £1.4 million, comprising new investment and match funding from the UKI2S Innovate Accelerator.

FDA Approval 147

FDA Approval Therapies FDA Molecular Biology 147

Drug Discovery World

AUGUST 7, 2024

The rest of the pharma R&D system — how drugs are developed, tested, approved, and manufactured — will need to accommodate this vast increase in speed and scale. Pharma R&D has been heading in the wrong direction, becoming progressively less efficient over the last few decades.

Pharma R&D 173

Pharma R&D Clinical Trials Pharma Companies Trials 173

Elrig

APRIL 29, 2024

Harini Srinivasan is a Principal Scientific Associate at Serna Bio with over 10 years of research experience in academic institutions, health care organizations and pharmaceutical companies. With a background in Bioinformatics and Computational Biology, she has a keen interest in using technology to solve problems in healthcare and medicine.

Bioinformatics 59

Bioinformatics Molecular Biology Drugs Cell Based Assays 59

Drug Discovery World

NOVEMBER 15, 2022

Gene-to-antibody production begins with scientists entering antibody sequences as starting material, after which bioinformatics tools filter out potentially non-viable sequences. They detect specific intracellular changes or the accumulation of small molecules of interest and then translate these into measurable outputs.

DNA 246

DNA Engineering Drugs Vaccine 246